drug adverse effects of PCSK9 inhibitor(s)
Jump to navigation
Jump to search
Adverse effects
- nasopharyngitis
- injection site reactions[2]
- uncertain effects on cognitive function[1]
- increased incidence of cataracts with LDL cholesterol < 25 mg/dL[1]
More general terms
References
- ↑ 1.0 1.1 1.2 Khan AR, Bavishi C, Riaz H et al. Increased risk of adverse neurocognitive outcomes with proprotein convertase subtilisin-kexin type 9 inhibitors. Circ Cardiovasc Qual Outcomes 2017 Jan; 10:e003153 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28073851 <Internet> http://circoutcomes.ahajournals.org/content/10/1/e003153
- ↑ 2.0 2.1 Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018